Gunnar Carsten Weikert
Directeur Général chez Inventages Venture Capital Investment, Inc
Profil
Gunnar Carsten Weikert is the founder of Inventages Venture Capital Investment, Inc. He currently holds positions as Chairman at Cognoptix, Inc., Non-Executive Director at CM&D Pharma Ltd., and Director at Phagenesis Ltd.
He formerly held positions as Director at DiObex, Inc., Cerecin, Inc., MSI Methylation Sciences, Inc., Atonomics A, SelectX Pharmaceuticals, Inc., Phytomedics, Inc., and OM Foods Ltd.
He was also a Senior VP & Global Head-Life Science Deals at Bayer AG.
He received an MBA and a doctorate from Heinrich-Heine-Universität Düsseldorf.
Postes actifs de Gunnar Carsten Weikert
| Sociétés | Poste | Début |
|---|---|---|
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London. | Directeur Général | - |
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Président | - |
CM&D Pharma Ltd.
 CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Directeur/Membre du Conseil | 09/12/2009 |
Phagenesis Ltd.
 Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom. | Directeur/Membre du Conseil | 07/11/2013 |
Anciens postes connus de Gunnar Carsten Weikert
| Sociétés | Poste | Fin |
|---|---|---|
Atonomics A/S
 Atonomics A/S Electronic Equipment/InstrumentsElectronic Technology Atonomics A/S provides diagnostic equipment for the biotechnology industries. Its product Atolyzer, is a microscopic biosensor that applies surface acoustic waves in the measurement of low levels of biomarkers in biological samples. The firm develops products for the benefit of health care professionals and patients. The company was founded by Thomas Warthoe, Peter Warthoe and Lars Bangsgaard on October 5, 2000 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Directeur/Membre du Conseil | - |
| BAYER AG | President | - |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Directeur/Membre du Conseil | - |
OM Foods Ltd.
 OM Foods Ltd. RestaurantsConsumer Services The Group's principal activity is to prepare and serve classic American cuisine with organic and natural ingredients. The Group's products include organic, natural and wholesome meals. The Group provides ham and cheese sandwiches to deli-style roast beef sandwiches and veggie packed salads. It's major customers are white collar office workers as well as students and employees of colleges and universities. The Group has twenty-six Retail Cafes in Seattle, Washington, Los Angeles, California and San Diego. | Directeur/Membre du Conseil | - |
Formation de Gunnar Carsten Weikert
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BAYER AG | Health Technology |
| Entreprise privées | 11 |
|---|---|
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London. | Finance |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Health Technology |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Health Technology |
OM Foods Ltd.
OM Foods Ltd. RestaurantsConsumer Services The Group's principal activity is to prepare and serve classic American cuisine with organic and natural ingredients. The Group's products include organic, natural and wholesome meals. The Group provides ham and cheese sandwiches to deli-style roast beef sandwiches and veggie packed salads. It's major customers are white collar office workers as well as students and employees of colleges and universities. The Group has twenty-six Retail Cafes in Seattle, Washington, Los Angeles, California and San Diego. | Consumer Services |
Cognoptix, Inc.
Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Health Services |
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Health Technology |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Atonomics A/S
Atonomics A/S Electronic Equipment/InstrumentsElectronic Technology Atonomics A/S provides diagnostic equipment for the biotechnology industries. Its product Atolyzer, is a microscopic biosensor that applies surface acoustic waves in the measurement of low levels of biomarkers in biological samples. The firm develops products for the benefit of health care professionals and patients. The company was founded by Thomas Warthoe, Peter Warthoe and Lars Bangsgaard on October 5, 2000 and is headquartered in Copenhagen, Denmark. | Electronic Technology |
